Molecular characterization of clinically defined aggressive variant prostate cancer (AVPCa) in prospectively collected tissues and corresponding patient derived xenografts (PDX).

被引：0
|
作者：
Aparicio, Ana [1 ]
Shen, Li [1 ]
Tapia, Elsa Li Ning [1 ]
Lu, Jing-Fang [1 ]
Chen, Hsiang-Chun [1 ]
Zhang, Jiexin [1 ]
Wu, Guanglin [1 ]
Wang, Xuemei [1 ]
Troncoso, Patricia [1 ]
Corn, Paul Gettys [1 ]
Thompson, Timothy C. [1 ]
Broom, Bradley McIntosh [1 ]
Baggerly, Keith A. [1 ]
Logothetis, Christopher [1 ]
Maity, Sankar N. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.5055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5055
引用
收藏
页数：1
相关论文
共 31 条
  • [11] Characterization of cancer stem cell subpopulations from patient-derived xenografts of advanced prostate cancer
    Karkampouna, Sofia
    De Menna, Marta
    Germann, Markus
    Grosjean, Joel
    Gray, Peter Clark
    Thalmann, George Niklaus
    Kruithof-de Julio, Marianna
    CANCER RESEARCH, 2018, 78 (13)
  • [12] Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource.
    Mack, Philip C.
    Bult, Carol J.
    Goodwin, Neal
    Airhart, Susan D.
    Burich, Rebekah
    Tepper, Clifford
    Lara, Primo
    Liu, Edison T.
    Gandara, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [13] Molecular characterization of a patient-derived xenograft (PDX) resource for triple negative breast cancer
    Graber, Joel H.
    Keck, James G.
    Airhart, Susan D.
    Bult, Carol J.
    Liu, Edison T.
    CANCER RESEARCH, 2015, 75
  • [14] CMS-PDX: A 20-gene genomic panel to predict consensus molecular subtypes in patient-derived xenografts (PDX) of colorectal cancer.
    Buechler, Steven Allen
    Gokmen-Polar, Yesim
    Badve, Sunil S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [15] Establishment and characterization of a panel of advanced prostate cancer patient-derived xenograft (PDX) models for cancer therapeutic evaluation
    Wang, Jessie Jingjing
    Chen, Leilei
    Yang, Xueying
    Zhang, Likun
    Qian, Wubin
    Li, Henry Qixiang
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [16] Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
    Lam, Hung-Ming
    McMullin, Ryan
    Nguyen, Holly M.
    Coleman, Ilsa
    Gormley, Michael
    Gulati, Roman
    Brown, Lisha G.
    Holt, Sarah K.
    Li, Weimin
    Ricci, Deborah S.
    Verstraeten, Karin
    Thomas, Shibu
    Mostaghel, Elahe A.
    Nelson, Peter S.
    Vessella, Robert L.
    Corey, Eva
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2301 - 2312
  • [17] Establishment and characterization of a panel of prostate cancer patient derived xenografts as an emerging platform for translational research.
    Schueler, Julia
    Lenhard, Dorothee
    Klingner, Kerstin
    Beshay, Janette
    Lashuk, Kanstantsin
    Oswald, Eva
    CANCER RESEARCH, 2021, 81 (13)
  • [18] Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature
    Jung, Jaeyun
    Lee, Hyun Cue
    Seol, Hyang Sook
    Choi, Yeon Sook
    Kim, Eunji
    Lee, Eun Ji
    Rhee, Je-Keun
    Singh, Shree Ram
    Jun, Eun Sung
    Han, Buhm
    Hong, Seung Mo
    Kim, Song Cheol
    Chang, Suhwan
    ONCOTARGET, 2016, 7 (38) : 62533 - 62546
  • [19] Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series
    Anselmino, Nicolas
    Labanca, Estefania
    Shepherd, Peter D. A.
    Dong, Jiabin
    Yang, Jun
    Song, Xiaofei
    Nandakumar, Subhiksha
    Kundra, Ritika
    Lee, Cindy
    Schultz, Nikolaus
    Zhang, Jianhua
    Araujo, John C.
    Aparicio, Ana M.
    Subudhi, Sumit K.
    Corn, Paul G.
    Pisters, Louis L.
    Ward, John F.
    Davis, John W.
    Vazquez, Elba S.
    Gueron, Geraldine
    Logothetis, Christopher J.
    Futreal, Andrew
    Troncoso, Patricia
    Chen, Yu
    Navone, Nora M.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2272 - 2285
  • [20] Abiraterone acetate (AA) treatment of prostate cancer patient-derived xenografts (PDX) demonstrates heterogeneity of responses and identifies potential biomarkers of adaptive resistance
    Lam, Hung-Ming
    McMullin, Ryan
    Nguyen, Holly M.
    Gormley, Michael
    Gulati, Roman
    Li, Weimin
    Ricci, Deborah
    Verstraeten, Karin
    Thomas, Shibu
    Mostaghel, Elahe A.
    Nelson, Peter S.
    Vessella, Robert L.
    Corey, Eva
    CANCER RESEARCH, 2015, 75
1234